<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>21</CFRTITLE>
    <CFRTITLETEXT>Food and Drugs</CFRTITLETEXT>
    <VOL>5</VOL>
    <DATE>2018-04-01</DATE>
    <ORIGINALDATE>2018-04-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Rheumatologic active ingredients.</TITLE>
    <GRANULENUM>Â§ 343.13</GRANULENUM>
    <HEADING>Section Â§ 343.13</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 21" SEQ="4">Food and Drugs</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="3">FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)</PARENT>
      <PARENT HEADING="SUBCHAPTER D" SEQ="2">DRUGS FOR HUMAN USE</PARENT>
      <PARENT HEADING="PART 343" SEQ="1">INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEU-MATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE</PARENT>
      <PARENT HEADING="Subpart B" SEQ="0">Active Ingredients</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 343.13</SECTNO>
    <SUBJECT>Rheumatologic active ingredients.</SUBJECT>
    <P>(a) Aspirin.</P>
    <P>(b) Buffered aspirin. Aspirin identified in paragraph (a) of this section may be buffered with any antacid ingredient(s) identified in § 331.11 of this chapter provided that the finished product contains at least 1.9 milliequivalents of acid-neutralizing capacity per 325 milligrams of aspirin as measured by the procedure provided in the United States Pharmacopeia 23/National Formulary 18.</P>
  </SECTION>
</CFRGRANULE>
